Back
Regeneron Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
REGN
Regeneron Pharmaceuticals
Last Price:
$633.98
Seasonality Move:
3.82%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.
Regeneron Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 645.48 | Sell |
| 20-day SMA: | 669.41 | Sell |
| 50-day SMA: | 681.86 | Sell |
| 200-day SMA: | 896.72 | Sell |
| 8-day EMA: | 645.61 | Sell |
| 20-day EMA: | 662.67 | Sell |
| 50-day EMA: | 688.18 | Sell |
| 200-day EMA: | 816.9 | Sell |
Regeneron Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -15.37 | Sell |
| Relative Strength Index (14 RSI): | 36.68 | Sell |
| Chaikin Money Flow: | 443283 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (650.34 - 703.3) | Sell |
| Bollinger Bands (100): | (668.63 - 768.13) | Sell |
Regeneron Pharmaceuticals Technical Analysis
| Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 634.23 while REGN 8-day simple moving average is 645.48, which is a Sell signal.
-
The stock price of REGN is 634.23 while Regeneron Pharmaceuticals 20-day SMA is 669.41, which makes it a Sell.
-
Regeneron Pharmaceuticals 50-day simple moving average is 681.86 while REGN share price is 634.23, making it a Sell technically.
-
REGN stock price is 634.23 and Regeneron Pharmaceuticals 200-day simple moving average is 896.72, creating a Sell signal.
REGN Technical Analysis vs Fundamental Analysis
Sell
32
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a SellThe current Regeneron Pharmaceuticals [REGN] share price is $634.23. The Score for REGN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
69.3B
Price in USD:
634.23
Share Volume:
1.1M
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
1,211.20
52-Week Low:
618.51
Sell
32
Regeneron Pharmaceuticals (REGN)
is a Sell
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?The Regeneron Pharmaceuticals stock price is 634.23 USD today.
-
Will REGN stock go up or go down?Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Regeneron Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 634.23 while REGN 8-day exponential moving average is 645.61, which is a Sell signal.
-
The stock price of REGN is 634.23 while Regeneron Pharmaceuticals 20-day EMA is 662.67, which makes it a Sell.
-
Regeneron Pharmaceuticals 50-day exponential moving average is 688.18 while REGN share price is 634.23, making it a Sell technically.
-
REGN stock price is 634.23 and Regeneron Pharmaceuticals 200-day simple moving average is 816.90, creating a Sell signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.70 per share, a decrease next quarter of $0.34 per share, a decrease this year of $2.34 per share, and an increase next year of $4.50 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
-
REGN Moving Average Covergence Divergence (MACD) indicator is -15.37, suggesting Regeneron Pharmaceuticals is a Sell
-
Regeneron Pharmaceuticals Relative Strength Index (RSI) is 36.68, which suggest Regeneron Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Regeneron Pharmaceuticals is (650.34 - 703.3), which suggest Regeneron Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Regeneron Pharmaceuticals is (668.63 - 768.13), which suggest Regeneron Pharmaceuticals is a Sell
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.